Treatment with once-daily transdermal rotigotine can improve Parkinsonian symptoms in patients with early Parkinson's Disease

Author：

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1424, 2004-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease

By Perez Lloret Santiago Rascol Olivier

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2221-2230

Informa Healthcare

Access to resources Recommend Favorite

Rotigotine Transdermal Patch: A Review of its Use in the Treatment of Parkinson's Disease

By Sanford Mark Scott Lesley J.

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 699-719

Adis International

Access to resources Recommend Favorite

Transdermal rotigotine effective adjunct in Parkinson's disease

Inpharma, Vol. 1, Iss. 1588, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Spotlight on Rotigotine Transdermal Patch in Parkinson's Disease†

By Sanford Mark Scott Lesley J.

Drugs & Aging, Vol. 28, Iss. 12, 2011-12 ,pp. : 1015-1017

Adis International

Access to resources Recommend Favorite

Rotigotine Transdermal Patch: A Review of its Use in the Management of Parkinson's Disease

By Baldwin Claudine M. Keating Gillian M.

CNS Drugs, Vol. 21, Iss. 12, 2007-01 ,pp. : 1039-1055

Adis International

Access to resources Recommend Favorite